BFRIW — Biofrontera Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1858685 ·
Last close
$0.06
Market Cap
—
52W High
$0.07
52W Low
$0.04
ADV30
0
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 10,084,000 | 7,968,000 | -3,928,000 | -4,752,000 | 24,787,000 | 6,317,000 | 18,717,000 |
| Dec 2025 | 17,100,000 | 14,091,000 | 4,559,000 | 5,640,000 | 28,564,000 | 6,392,000 | 18,084,000 |
| Sep 2025 | 6,988,000 | 4,943,000 | -6,278,000 | -6,649,000 | 15,415,000 | 3,417,000 | 17,996,000 |
| Jun 2025 | 9,030,000 | 6,388,000 | -5,079,000 | -5,324,000 | 20,142,000 | 7,239,000 | 24,810,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-13,361,000
Investing CF
$2,998,000
Financing CF
$10,850,000
CapEx
$-5,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-127,945,000
Inventory
$1,426,000
Receivables
$8,509,000
ST Investments
$9,000
EBIT TTM
$-9,702,000
Pretax Income TTM
$-10,510,000
Interest Exp TTM
$299,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$43,201,000
EBITDA
$-10,565,000
Free Cash Flow
$1,477,000
Enterprise Value
—
Total Cash
$6,326,000
Total Debt
$7,724,000
Shares Out
—
Trailing EPS
$-1.30
Book Value
$0.90
ROE
-339.0%
ROA
-32.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 41,705,000 | -11,348,000 | -10,536,000 | 28,564,000 | 18,084,000 | — | -13,361,000 |
| Dec 2024 | 37,321,000 | -17,210,000 | -17,759,000 | 22,101,000 | 17,668,000 | — | -10,270,000 |
| Dec 2023 | 34,071,000 | -22,577,000 | -20,131,000 | 27,932,000 | 23,139,000 | — | -24,895,000 |
| Dec 2022 | 28,674,000 | -22,381,000 | -640,000 | 50,884,000 | 27,006,000 | — | -16,199,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $949.47B | $1064.74 | — |
| JNJ | JOHNSON & JOHNSON | $554.09B | $230.18 | — |
| ABBV | AbbVie Inc. | $376.54B | $213.12 | — |
| MRK | Merck & Co., Inc. | $295.69B | $119.72 | — |
| AZN | ASTRAZENECA PLC | $290.30B | $187.19 | — |
News headlines (Yahoo Finance, 1h cache)
Biofrontera Inc (BFRI) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ...
2026-05-14 23:04 · Yahoo
Biofrontera Inc. (BFRI) Reports Q1 Loss, Beats Revenue Estimates
2026-05-14 13:25 · Yahoo
Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update
2026-05-14 11:30 · Yahoo
Biofrontera Launches Second Annual “Hats On” Campaign to Raise Awareness of Actinic Keratosis
2026-05-13 13:00 · Yahoo
Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026
2026-05-08 20:00 · Yahoo
Biofrontera Inc (BFRI) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...
2026-03-21 01:01 · Yahoo
Biofrontera (BFRI) Q4 2025 Earnings Transcript
2026-03-19 15:17 · Yahoo
Biofrontera Inc. Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
2026-03-19 13:25 · Yahoo
Biofrontera Inc. Announces Filing of Supplemental New Drug Application (sNDA) for the Treatment of Superficial Basal Cell Carcinoma (sBCC) with Ameluz®-PDT
2025-12-02 13:45 · Yahoo
Pelthos Therapeutics Acquires Xepi® (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing
2025-11-07 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.